ArticleCNS neuroscience & therapeutics2018

A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Xiao-Lu Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.